PET molecular imaging in stem cell therapy for neurological diseases

Review Article

DOI: 10.1007/s00259-011-1860-7

Cite this article as:
Wang, J., Tian, M. & Zhang, H. Eur J Nucl Med Mol Imaging (2011) 38: 1926. doi:10.1007/s00259-011-1860-7


Human neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, spinal cord injury and multiple sclerosis are caused by loss of different types of neurons and glial cells in the brain and spinal cord. At present, there are no effective therapies against these disorders. Discovery of the therapeutic potential of stem cells offers new strategies for the treatment of neurological diseases. Direct assessment of stem cells’ survival, interaction with the host and impact on neuronal functions after transplantation requires advanced in vivo imaging techniques. Positron emission tomography (PET) is a potential molecular imaging modality to evaluate the viability and function of transplanted tissue or stem cells in the nervous system. This review focuses on PET molecular imaging in stem cell therapy for neurological diseases.


Positron emission tomography (PET) Stem cell therapy Neurological disease 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Department of Nuclear MedicineSecond Affiliated Hospital of Zhejiang University School of MedicineHangzhou, ZhejiangChina
  2. 2.Zhejiang University Medical PET CenterHangzhouChina
  3. 3.Institute of Nuclear Medicine and Molecular Imaging of Zhejiang UniversityHangzhouChina
  4. 4.Key Laboratory of Medical Molecular Imaging of Zhejiang ProvinceHangzhouChina
  5. 5.Department of Experimental Diagnostic ImagingThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations